查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1403390

到 2030 年分子生物酶市场预测：按产品、应用、最终用户和地区分類的全球分析

Molecular Biology Enzymes Market Forecasts to 2030 - Global Analysis By Product (Enzymes, Kits & Reagents, DNA Extraction, Isothermal Amplification and Other Products), Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC预测，2023年全球分子生物酶市场规模将达206亿美元，预计2030年将达到590亿美元，预测期内复合年增长率为16.2%。

在分子生物学中，酵素是一种特殊的蛋白质，可作为催化剂加速并促进生物体的代谢过程。酵素的工作原理是降低某些化学反应发生所需的活化能，加速这些反应，而不消耗或改变过程中的资源。酶是高度专业化的，因为它们是为了催化特定过程或一组相关事件而创建的。

根据世界卫生组织（WHO）的调查，约有12,368人流感病毒检测呈阳性，其中8,423人（68.1%）感染甲型流感，3,945人（31.9%）感染B型流感。

成长动力：增加基因计划

免疫系统疾病、代谢性疾病、癌症、先天性遗传性疾病等疾病的发生和发展很大程度上受基因突变的影响。由于世界各地开展的基因组计划数量不断增加以及与遗传分析相关的成本不断下降，包括疾病治疗、个体化医疗和微生物遗传学在内的许多领域的研究正在取得进展。预计市场将受到这些需要使用各种酵素和试剂的程序的推动。

成长抑制因素：基因检测报销限制

保险报销限制限制了基因检测所需的某些分子生物酶的可用性。好的酶可能很昂贵。如果研究费用无法涵盖全部费用，实验室和研究中心可能会选择使用更便宜的替代品，从而降低测试的准确性和效率。有限的报销阻碍了创造更新、更有效率酵素的研发工作，从而阻碍了市场成长。

成长机会：不断进步

分子生物学研究的不断进步以及蛋白质组学、基因组学和重组 DNA 技术等行业对酶的各种应用的需求推动了对专用酶的需求。此外，重组 DNA、蛋白质工程和酶工程的进步正在生产具有增强特性的新酶，有助于扩大市场。

威胁：监管障碍

分子生物学中使用的酶，尤其是临床和医疗环境中使用的酶，经常受到严格的监管监督。确保合规性和满足监管要求可能是一个成本高且耗时的过程。遵守监管要求并完成新酶或修饰的核准流程可能既昂贵又耗时。这是限制市场拓展的主要因素。

COVID-19 的影响

研究目标的重点已在很大程度上从分子生物学的其他领域转移到与 COVID-19 相关的研究。这正在影响用于各种研究和应用的特定酶品种的市场。由于人手不足、运输限制和封锁，供应链遭受了严重破坏。这影响了各种实验室用品的可得性，包括分子生物学中使用的酵素。

预计在预测期内套件和试剂部分将是最大的

套件和试剂部分预计将成为预测期内最大的部分。这是由于这些产品在市场上的大量可得性、新的开发以及主要企业不断推出的产品。由于克隆技术作为标准实验室程序的持续发展以及分子生物学领域的扩展，预计酶在预测期内将以最快的速度增长。这使得製造商和供应商能够提供多种用于核酸操作的酵素。

製药和生物技术公司领域预计在预测期内复合年增长率最高

製药和生物技术公司领域预计在预测期内复合年增长率最高。这是由促进工作流程的分子生物学产品的普及所推动的。随着製药和生技公司研究候选药物、个体化医疗、诊断等，这些产品的便利性和有效性强化了他们的提案，从而增加了收益。未来几年，分子技术阶段研发和临床试验的广泛采用将推动市场的发展。

比最大的地区

由于临床和转化研究方面的研究支出增加以及各国生物技术和製药公司数量的快速增加，预计北美在预测期内将占据最大的市场占有率。慢性病在所有年龄层的盛行率以及癌症在社区中的普遍存在导致人们对预防和治疗方案的研究不断增加。老字型大小企业的存在和采用新技术的便利性被认为是推动该地区收益成长的主要因素。

复合年增长率最高的地区

预计亚太地区在预测期内将维持最高的复合年增长率。由于医疗保健系统不足、人口众多、对针对性治疗的需求不断增长以及经济快速扩张，分子生物学製造商看到了巨大的发展潜力。此外，正是这些国家不断增长的消费能力，促使西方企业在这些国家推出新产品并获得市场支配力，导致市场收益下降。

免费客製化服务：

订阅此报告的客户可以利用以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争关係

第五章全球分子生物酶市场：副产品

  • 酵素
    • 聚合酶
    • 限制性核酸内切酶
    • 逆转录酶
    • 连接酶
    • 磷酸酶
    • 蛋白酶和蛋白酶
  • 套件和试剂
    • 可冷冻干燥和风干
    • 下一代定序
    • 聚合酶炼式反应
  • DNA萃取
  • 等温扩增
  • 其他产品

第六章全球分子生物酶市场：依应用分类

  • 磊晶
  • 复製
  • 顺序
  • 消化受限
  • 合成生物学
  • 其他用途

第七章全球分子生物学酶市场：依最终用户分类

  • 学术研究所
  • 製药和生物技术公司
  • 医院和诊断中心
  • 其他最终用户

第八章全球分子生物酶市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第九章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十章 公司简介

  • Illumina, Inc.
  • Merck KGAA
  • Bioline Technologies
  • Promega Corporation
  • Rockland Immunochemicals
  • Qiagen
  • Agilent Technologies, Inc.
  • Jena Bioscience GmbH
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Bio-Rad Laboratories, Inc.
  • Takara Bio, Inc.
  • LGC Limited
  • Bausch Health Companies Inc.
Product Code: SMRC24615

According to Stratistics MRC, the Global Molecular Biology Enzymes Market is accounted for $20.6 billion in 2023 and is expected to reach $59.0 billion by 2030 growing at a CAGR of 16.2% during the forecast period. In molecular biology, enzymes are specialized proteins that function as catalysts to quicken and ease metabolic processes in living things. They function by reducing the activation energy needed for a certain chemical reaction to take place, which speeds up these reactions without consuming any resources or changing them in the process. Because they are made to catalyze certain processes or groups of related events, enzymes are extremely specialized.

According to a survey conducted by the World Health Organization, approximately 12,368 individuals were positive for influenza viruses, of which 8,423 (68.1%) were typed as influenza A and 3,945 (31.9%) as influenza B.

Market Dynamics:

Driver:

Increasing amount of genomic projects

The genesis and progression of illnesses such immune system disorders, metabolic diseases, cancer, and inborn genetic disorders are significantly influenced by gene mutations. Research in a number of areas, including illness treatment, customized medicine, and microbial genetics, is advanced by the growing number of genome projects being undertaken worldwide and the declining costs associated with genetic analysis. The market is anticipated to be driven by these procedures, which call for the employment of a variety of enzymes and reagents.

Restraint:

Limited reimbursements for genetic testing

Reimbursement limitations limit the availability of specific molecular biology enzymes needed for genetic testing. Good enzymes can be costly; if reimbursements do not cover the entire cost, labs or research centers may choose to use less expensive substitutes, which may reduce test accuracy or efficiency. Research and development attempts to create newer, more efficient enzymes are hampered by limited reimbursement, which is hampering the growth of the market.

Opportunity:

Rising advancements

The need for specialized enzymes is driven by ongoing advances in molecular biology research as well as the necessity of enzymes for a variety of applications in industries including proteomics, genomics, and recombinant DNA technology. Additionally, advances in recombinant DNA, protein engineering, and enzyme engineering result in the production of new enzymes with enhanced characteristics, which propels market expansion.

Threat:

Regulatory hurdles

Strict regulatory oversight is frequently imposed on enzymes utilized in molecular biology, particularly when these enzymes are used in clinical or medical contexts. Ensuring compliance and meeting regulatory requirements may be costly and time-consuming procedures. It can be costly and time-consuming to comply with regulatory requirements and go through the approval procedures for new enzymes or changes. This is the main factor limiting the market's expansion.

COVID-19 Impact:

The focus of research goals moved significantly from other fields of molecular biology study to COVID-19-related investigations. This has an effect on the market for certain enzyme varieties utilized in various studies and applications. The supply chain experienced major interruptions as a result of manpower constraints, transit restrictions, and lockdowns. This has an impact on the availability of various lab supplies including enzymes used in molecular biology.

The kits & reagents segment is expected to be the largest during the forecast period

The kits & reagents segment is expected to be the largest during the forecast period. This can be attributed to the vast availability of these products in the market space, novel developments, and continuous product launches from key players. Enzymes are expected to rise at the quickest rate over the projection period due to the ongoing development of cloning technology as a standard laboratory procedure and the expanding field of molecular biology. This has allowed the manufacturers and suppliers to provide multiple enzymes for nucleic acid manipulation.

The pharmaceutical & biotechnology companies segment is expected to have the highest CAGR during the forecast period

The pharmaceutical & biotechnology companies segment is expected to have the highest CAGR during the forecast period. This can be attributed to the widespread adoption of molecular biology products that facilitate workflow. The convenience and effectiveness of these goods during the pharma and biotech businesses' research for drug candidates, customized medicine, or diagnostics enhances their offers and, as a result, increases revenues. In the upcoming years, the market will be driven by the widespread adoption of molecular technologies by businesses throughout the R&D and clinical trials phases.

Region with largest share:

North America is projected to hold the largest market share during the forecast period due to increase in research funds in clinical & translational research and surge in number of biotechnology & pharmaceutical companies in nations. Research on preventive and treatment options is growing due to the prevalence of chronic illnesses in all age groups and the ubiquity of cancer in the community. The presence of well-established players ease of adoption of new technologies are considered to be the major factors fueling revenue generation in this region.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period the presence of bio-clusters in the nations. Manufacturers of molecular biology have found great development potential due to the deficient healthcare systems, large population, increased need for focused therapeutics, and quick economic expansion. Further encouraging western corporations to introduce new goods and win market dominance in these countries is the rising spending power of these nations, which in turn has increased market revenue.

Key players in the market:

Some of the key players in Molecular Biology Enzymes market include Illumina, Inc., Merck KGAA, Bioline Technologies, Promega Corporation, Rockland Immunochemicals, Qiagen, Agilent Technologies, Inc., Jena Bioscience GmbH, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Takara Bio, Inc., LGC Limited and Bausch Health Companies Inc.

Key Developments:

In October 2022, Illumina Inc. announced strategic research collaboration with AstraZeneca, a global, science-led biopharmaceutical company, to accelerate drug target discovery by combining their strengths in artificial intelligence (AI) based genome interpretation and genomic analysis techniques along with industry expertise.

In September 2021, Thermo Fisher Scientific has announced the launch of its fully-automated analyzers specifically designed for enzyme assay applications. The systems combine hardware and new custom-designed software to deliver fully automated incubation settings, reagent additions and precise measurement calculations, all at the touch of a button.

Products Covered:

  • Enzymes
  • Kits & Reagents
  • DNA Extraction
  • Isothermal Amplification
  • Other Products

Applications Covered:

Polymerase Chain Reaction (PCR)

  • Epigenetics
  • Cloning
  • Sequencing
  • Restriction Digestion
  • Synthetic Biology
  • Other Applications

End Users Covered:

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostic Centres
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Molecular Biology Enzymes Market, By Product

  • 5.1 Introduction
  • 5.2 Enzymes
    • 5.2.1 Polymerases
    • 5.2.2 Restriction Endonucleases
    • 5.2.3 Reverse Transcriptases
    • 5.2.4 Ligases
    • 5.2.5 Phosphatases
    • 5.2.6 Proteases and Proteinases
  • 5.3 Kits & Reagents
    • 5.3.1 Lyophilisable and Air Dryable
    • 5.3.2 Next-Generation Sequencing
    • 5.3.3 Polymerase Chain Reaction
  • 5.4 DNA Extraction
  • 5.5 Isothermal Amplification
  • 5.6 Other Products

6 Global Molecular Biology Enzymes Market, By Application

  • 6.1 Introduction

6.2 Epigenetics

  • 6.3 Cloning
  • 6.4 Sequencing
  • 6.5 Restriction Digestion
  • 6.6 Synthetic Biology
  • 6.7 Other Applications

7 Global Molecular Biology Enzymes Market, By End User

  • 7.1 Introduction
  • 7.2 Academic & Research Institutes
  • 7.3 Pharmaceutical & Biotechnology Companies
  • 7.4 Hospitals & Diagnostic Centres
  • 7.5 Other End Users

8 Global Molecular Biology Enzymes Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Illumina, Inc.
  • 10.2 Merck KGAA
  • 10.3 Bioline Technologies
  • 10.4 Promega Corporation
  • 10.5 Rockland Immunochemicals
  • 10.6 Qiagen
  • 10.7 Agilent Technologies, Inc.
  • 10.8 Jena Bioscience GmbH
  • 10.9 Thermo Fisher Scientific, Inc.
  • 10.10 F. Hoffmann-La Roche Ltd.
  • 10.11 Bio-Rad Laboratories, Inc.
  • 10.12 Takara Bio, Inc.
  • 10.13 LGC Limited
  • 10.14 Bausch Health Companies Inc.

List of Tables

  • Table 1 Global Molecular Biology Enzymes Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Molecular Biology Enzymes Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Molecular Biology Enzymes Market Outlook, By Enzymes (2021-2030) ($MN)
  • Table 4 Global Molecular Biology Enzymes Market Outlook, By Polymerases (2021-2030) ($MN)
  • Table 5 Global Molecular Biology Enzymes Market Outlook, By Restriction Endonucleases (2021-2030) ($MN)
  • Table 6 Global Molecular Biology Enzymes Market Outlook, By Reverse Transcriptases (2021-2030) ($MN)
  • Table 7 Global Molecular Biology Enzymes Market Outlook, By Ligases (2021-2030) ($MN)
  • Table 8 Global Molecular Biology Enzymes Market Outlook, By Phosphatases (2021-2030) ($MN)
  • Table 9 Global Molecular Biology Enzymes Market Outlook, By Proteases and Proteinases (2021-2030) ($MN)
  • Table 10 Global Molecular Biology Enzymes Market Outlook, By Kits & Reagents (2021-2030) ($MN)
  • Table 11 Global Molecular Biology Enzymes Market Outlook, By Lyophilisable and Air Dryable (2021-2030) ($MN)
  • Table 12 Global Molecular Biology Enzymes Market Outlook, By Next-Generation Sequencing (2021-2030) ($MN)
  • Table 13 Global Molecular Biology Enzymes Market Outlook, By DNA Extraction (2021-2030) ($MN)
  • Table 14 Global Molecular Biology Enzymes Market Outlook, By Isothermal Amplification (2021-2030) ($MN)
  • Table 15 Global Molecular Biology Enzymes Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 16 Global Molecular Biology Enzymes Market Outlook, By Application (2021-2030) ($MN)
  • Table 17 Global Molecular Biology Enzymes Market Outlook, By Polymerase Chain Reaction (2021-2030) ($MN)
  • Table 18 Global Molecular Biology Enzymes Market Outlook, By Epigenetics (2021-2030) ($MN)
  • Table 19 Global Molecular Biology Enzymes Market Outlook, By Cloning (2021-2030) ($MN)
  • Table 20 Global Molecular Biology Enzymes Market Outlook, By Sequencing (2021-2030) ($MN)
  • Table 21 Global Molecular Biology Enzymes Market Outlook, By Restriction Digestion (2021-2030) ($MN)
  • Table 22 Global Molecular Biology Enzymes Market Outlook, By Synthetic Biology (2021-2030) ($MN)
  • Table 23 Global Molecular Biology Enzymes Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 24 Global Molecular Biology Enzymes Market Outlook, By End User (2021-2030) ($MN)
  • Table 25 Global Molecular Biology Enzymes Market Outlook, By Academic & Research Institutes (2021-2030) ($MN)
  • Table 26 Global Molecular Biology Enzymes Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 27 Global Molecular Biology Enzymes Market Outlook, By Hospitals & Diagnostic Centres (2021-2030) ($MN)
  • Table 28 Global Molecular Biology Enzymes Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.